structural communications
Solution structure of an arsenate reductase-related protein, YffB, from Brucella melitensis, the etiological agent responsible for brucellosis
aSeattle Structural Genomics Center for Infectious Disease, https://www.ssgcid.org , USA,bBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington, USA,cDepartment of Medicine, University of Washington, Seattle, Washington, USA,dSeattle Biomedical Research Institute, Seattle, Washington, USA, and eDepartment of Medical Education and Biomedical Informatics and Department of Global Health, University of Washington, Seattle, Washington, USA
*Correspondence e-mail: garry.buchko@pnnl.gov
Brucella melitensis is the etiological agent responsible for brucellosis. Present in the B. melitensis genome is a 116-residue protein related to arsenate reductases (Bm-YffB; BR0369). Arsenate reductases (ArsC) convert arsenate ion (H2AsO4−), a compound that is toxic to bacteria, to arsenite ion (AsO2−), a product that may be efficiently exported out of the cell. Consequently, Bm-YffB is a potential drug target because if arsenate reduction is the protein's major biological function then disabling the cell's ability to reduce arsenate would make these cells more sensitive to the deleterious effects of arsenate. and NMR spectroscopy indicate that Bm-YffB is a monomer in solution. The solution structure of Bm-YffB (PDB entry 2kok ) shows that the protein consists of two domains: a four-stranded mixed β-sheet flanked by two α-helices on one side and an α-helical bundle. The α/β domain is characteristic of the fold of thioredoxin-like proteins and the overall structure is generally similar to those of known arsenate reductases despite the marginal sequence similarity. perturbation studies with 15N-labeled Bm-YffB show that the protein binds reduced glutathione at a site adjacent to a region similar to the HX3CX3R catalytic sequence motif that is important for arsenic detoxification activity in the classical arsenate-reductase family of proteins. The latter observation supports the hypothesis that the ArsC-YffB family of proteins may function as glutathione-dependent thiol reductases. However, comparison of the structure of Bm-YffB with the structures of proteins from the classical ArsC family suggest that the mechanism and possibly the function of Bm-YffB and other related proteins (ArsC-YffB) may differ from those of the ArsC family of proteins.
Keywords: arsenate reductases; Brucella melitensis; YffB; brucellosis.
3D view: 2kok
PDB reference: Bm-YffB, 2kok
1. Introduction
Brucella melitensis is a facultative intracellular bacterial pathogen that exhibits a host preference for goats and sheep. It is one of the Brucella species identified as being responsible for brucellosis, a zoonotic disease that causes abortions and stillbirths in animals and Malta fever in humans. The disease is transmitted to humans primarily via contact with infected animals (alive or dead) or the consumption of unpasteurized dairy products (Young, 1995). In undeveloped regions of the Mediterranean, Asia, Africa and Latin America brucellosis infections are a major problem in livestock and human populations, causing severe economic hardship (Corbel, 1997). In humans, the disease is multi-systemic and the symptoms are nonspecific, including fever, chills, malaise, dementia, fatigue, headaches, nausea, vomiting and constipation. Infections can be successfully treated with antimicrobial agents that are able to penetrate well into the host cells, often a combination of doxycycline and streptomycin or doxycycline and rifampin for prolonged periods of time (Young, 1995; Rubinstein et al., 1991). There is much interest in the pathobiology of strains of Brucella because it is a potential agent of biological warfare and its pathogenicity is unique in that the organism does not display any obvious `classical' virulence factors (Moreno & Moriyon, 2002).
Arsenic, a naturally occurring metalloid element that is frequently abundant in the environment (Messens & Silver, 2006), is a human carcinogen (Shi et al., 2004) that is also toxic to most forms of life. The toxic effects arise from the reactivity of arsenic ions with protein To counter the toxic effects, a family of arsenic detoxification enzymes has evolved that convert arsenate ion (H2AsO4−), the highly reactive form of arsenic, to arsenite ion (AsO2−), a compound that may be effectively transported outside the cell (Mukhopadhyay et al., 2002). In B. melitensis, YffB, a protein with marginal sequence similarity to the classical family of arsenate reductases (ArsC), is found that may play a role in reducing arsenate (DelVecchio et al., 2002). This 13.5 kDa protein (Bm-YffB) is a potential drug target because if arsenate reduction is this protein's major biological function, contributing to the organism's virulence, then disabling this protein and the cell's ability to reduce arsenate would make B. melitensis more sensitive to the deleterious effects of endogenous arsenate. Towards understanding the biological function of Bm-YffB and providing a blueprint for structure-based drug design (Myler et al., 2009) based on this protein, the solution structure of Bm-YffB was determined. Its thermostability was measured by CD spectroscopy and its structure was compared with those of a similar protein, Pseudomonas aeruginosa YffB (Pa-YffB; PDB entry 1rw1 ; Teplyakov et al., 2004), and a protein known to reduce arsenate, Escherichia coli ArsC (Ec-ArsC; PDB entry 1id9 ; Martin et al., 2001).
2. Materials and methods
2.1. Cloning, expression and purification
The Bm-Yffb gene (BR0369; YP_4138591.1) was amplified using the genomic DNA of B. melitensis biovar Abortus 2308 and the oligonucleotide primers 5′-GGGTCCTGGTTCGATGAGTGTGACCATTTACGGCATC-3′ (forward) and 5′-CTTGTTCGTGCTGTTTATTATAGCTTAAAATAAGCTTCATACTGCG-3′ (reverse) (Invitrogen, Carlsbad, California, USA). The amplified Bm-YffB gene was then gel-purified, treated with T4 DNA polymerase and annealed into the NruI/PmeI-digested expression vector AVA0421 at a site that provided a 21-residue tag containing six consecutive histidine residues (MAHHHHHHMGTLEAQTQGPGS-) at the N-terminus of the expressed protein (Choi et al., 2011). The recombinant plasmid was transformed into E. coli BL21(DE3)R3-pRARE2 cells (a gift from SGC Toronto, Toronto, Ontario, Canada) using a heat-shock method. Uniformly 15N- and 15N-,13C-labeled Bm-YffB was obtained by growing the transformed cells (310 K) in minimal medium (Miller) containing 15NH4Cl (1 mg ml−1) and D-[13C6]-glucose (2.0 mg ml−1) supplemented with FeCl3 (50 µg ml−1) and the antibiotics chloramphenicol (35 µg ml−1) and ampicillin (100 µg ml−1). Once the cells reached an OD600 of ∼0.8, the cells were cooled to 298 K and protein expression was induced with isopropyl β-D-1-thiogalactopyranoside (0.026 µg ml−1). After approximately 5 h, the cells were harvested by mild centrifugation and frozen at 193 K. The frozen pellet was later thawed and resuspended in ∼35 ml lysis buffer (0.3 M NaCl, 50 mM sodium phosphate, 10 mM imidazole, pH 8.0) brought to 0.2 mM phenylmethylsulfonyl fluoride (PMSF) prior to three passes through a French press (SLM Instruments, Rochester, New York, USA). Following 60 s sonication (SLM Instruments, Rochester, New York, USA) the cell debris was pelleted by centrifugation at 25 000g for 1 h in a JA-20 rotor (Beckman Instruments, Fullerton, California, USA). The supernatant was then passed through a 0.45 µm syringe filter and applied onto an Ni–NTA affinity column (Qiagen, Valencia, California, USA) containing ∼25 ml resin. The column was washed stepwise by gravity with 40 ml buffer (0.3 M NaCl, 50 ml sodium phosphate pH 8.0) containing increasing concentrations of imidazole (5, 10, 20, 50 and 250 mM). Bm-YffB eluted primarily in the 250 mM imidazole wash. Following exchange into 3C cleavage buffer by overnight dialysis in 4 l cleavage buffer (150 mM NaCl, 20 mM Tris–HCl, pH 8.4) the protein was concentrated to ∼2 ml (Amicon Centriprep-10) and the N-terminal polyhistidine tag was removed by overnight incubation with 3C protease (1 µg per 50 µg target protein) at 279 K (Bryan et al., 2011). Using a flow rate of 1.0 ml min−1, the reaction solution was then loaded onto a Superdex 75 HiLoad 16/60 column (GE Healthcare, Piscataway, New Jersey, USA) to simultaneously purify the protein and exchange it into NMR buffer (100 mM NaCl, 20 mM Tris–HCl, 1.0 mM dithiothreitol, pH 7.1). The band containing Bm-YffB (retention time 78 min) was collected and the volume was reduced (Amicon Centriprep-10) to generate NMR samples in the 1–2 mM range (Lowry analysis). SDS–PAGE analysis of the final NMR samples showed the protein to be greater than ∼95% pure.
2.2. spectroscopy
An Aviv Model 410 spectropolarimeter (Lakewood, New Jersey, USA) calibrated with an aqueous solution of ammonium D-(+)-camphorsulfonate was used to collect data from a 0.05 mM Bm-YffB sample in NMR buffer in a quartz cell of 0.1 cm path length. A thermal curve was obtained by recording the ellipticity at 216 nm in 2.0 K intervals from 283 to 353 K. A quantitative estimation of the melting temperature, Tm, was obtained by taking a first derivative of the thermal curve using the Aviv software (Greenfield, 2006). Steady-state wavelength spectra for Bm-YffB were recorded in 0.5 nm increments between 200 and 260 nm at 298 and 353 K. Each reported steady-state wavelength spectrum was the result of averaging two consecutive scans with a bandwidth of 1.0 nm and a time constant of 1.0 s. These spectra were processed by subtracting a blank spectrum from the protein spectrum and then automatically line-smoothing the data using the Aviv software.
2.3. Nuclear magnetic resonance spectroscopy
Varian 800-, 750- and 600-Inova spectrometers equipped with 1H/13C/15N triple-resonance probes and pulse-field gradients were used to collect the NMR data required for resonance assignments and The NMR data, which were collected from 1–2 mM samples at 293 K, were processed with Felix2007 (Felix NMR Inc., San Diego, California, USA) and analyzed with Sparky (v.3.115; Goddard & Kneller, 2008). Assignments of the 1H, 13C and 15N chemical shifts for the backbone and side-chain resonances were made from standard 2D 1H–15N HSQC, 1H–13C HSQC, HBCBCGCDHD and HBCBCGCDCHE experiments and 3D HNCACB, CBCA(CO)NH, HNCO, HCC-TOCSY-NNH and CC-TOCSY-NNH experiments using Varian Protein Pack pulse programs. Chemical shifts were referenced to DSS (DSS = 0 p.p.m.) using indirect methods (Wishart et al., 1995). Distance restraints were obtained from a suite of 3D 13C- and 15N-edited NOESY-HSQC experiments using a mixing time of 80 ms. Deuterium-exchange studies were performed by lyophilizing a 15N-labeled NMR sample, re-dissolving it in 99.8% D2O and immediately collecting 1H–15N HSQC spectra 10, 20 and 60 min after exchange. An overall rotational correlation time, tc, was estimated from backbone-amide 15N T1/T1ρ ratios (Farrow et al., 1994; Buchko et al., 2008). A perturbation experiment was performed by adding aliquots of reduced glutathione in NMR buffer (50 mM) to a 0.5 mM sample of 15N-labeled Bm-YffB. Following gentle agitation, 1H–15N HSQC spectra were collected at glutathione:Bm-YffB molar ratios of 0.3:1, 0.6:1, 1:1 and 2:1.
2.4. Structure calculations
The chemical shifts for Bm-YffB were assigned using conventional methods (Cavanagh et al., 1996) and were deposited in the Biological Magnetic Resonance Data Bank (BMRB) under accession No. 16517. Using these 1H, 13C and 15N assignments and the peak-picked data from 13C- and 15N-edited NOESY-HSQC experiments as initial inputs, structure calculations were performed iteratively using CYANA (v.2.1; Güntert, 2004). 184 dihedral angle restraints for both φ and ψ were introduced on the basis of the elements of secondary structure identified in the early structural ensembles and TALOS calculations (Cornilescu et al., 1999). Near the end of the iterative process, 84 hydrogen-bond restraints (1.8–2.0 and 2.7–3.0 Å for the NH—O and N—O distances, respectively) were introduced into the structure calculations on the basis of proximity in early structure calculations and the observation of slowly exchanging in the deuterium-exchange experiment. On the basis of the difference between the proline 13Cβ and 13Cγ atoms (Schubert et al., 2002), Pro93 was placed in the cis conformation. From the final set of 100 calculated structures, the 20 with the lowest target function were selected and this ensemble was deposited in the Protein Data Bank (PDB) under PDB code 2kok . Structural quality was assessed using the Protein Structure Validation Suite (PSVS; v.1.3; Bhattacharya et al., 2007). Note that the deposited structures were not refined with explicit water (Linge et al., 2003) because these calculations continuously introduced unfavorable steric clashes into the structures despite numerous attempts to adjust the parameters. A summary of the structure statistics is provided in Table 1.
‡Calculated for the central ordered core, Ser2–Ile8 and Cys11–Lys115, using PSVS. §Z scores; values in parentheses are raw values. |
The amino-acid sequence of Bm-YffB deposited in the PDB and BMRB is numbered sequentially, Gly1–Leu120, starting with the four non-native residues (GPGS-) that remained after 3C protease treatment. However, here the first four non-native residues are numbered sequentially with asterisks (Gly1*–Ser4*) and the first native residue, Met5 in the PDB and BMRB depositions, is labeled Met1.
3. Results and discussion
3.1. Solution structure of Bm-ArsC
The elution time of Bm-YffB on a Superdex 75 HiLoad 16/60 column was within a range consistent with a monomeric ∼14 kDa protein (data not shown). Such a conclusion was corroborated by the experimentally estimated rotational correlation time determined for Bm-YffB, 9.1 ± 0.2 ns (293 K), a value that is more consistent with a monomeric ∼14 kDa protein than an ∼28 kDa dimer (Bhattacharjya et al., 2004). The line widths and dispersion of the 1H–15N HSQC spectrum for Bm-YffB, shown in Fig. 1, were also characteristic of a folded monomeric protein with a molecular weight in the 15 kDa range. As illustrated in Fig. 1, 121 of the expected 123 amide resonances for Bm-YffB [120 − (6 prolines + Gly1*)] were assigned in the 1H–15N HSQC spectrum. Amide cross-peaks for Asp16 and Phe109 were not unambiguously identified. On the basis of these amide assignments and extensive assignment of the 13Cα and side-chain proton and carbon chemical shifts (BMRB ID 16517), an ensemble of structures was calculated (Fig. 2a) that satisfied all of the available experimental NMR data (NOEs, chemical shifts, deuterium-exchange experiments and TALOS calculations).
As summarized in Table 1, a total of 1490 interproton distance restraints, 84 hydrogen-bond restraints and 188 dihedral angle restraints were used in the final structure calculations. Each member of the final ensemble of 20 calculated structures agreed well with the experimental data, with no upper limit violation of greater than 0.05 Å and no torsion-angle violation of greater than 2°. Analysis of the ensemble with the PSVS validation-software package (Bhattacharya et al., 2007) also showed that the quality of the structures in the final ensemble was good. The Ramachandran statistics for all residues in the ensemble were overwhelmingly in acceptable space [90% of the (φ, ψ) pairs for Bm-YffB were found in the most favored regions and 10% were within additionally allowed regions] and all the structure-quality Z scores were acceptable (>−5).
The final set of 20 calculated structures in the ensemble converge well, as shown mathematically by the statistics in Table 1 and visually by the superposition in Fig. 2(a). The r.m.s.d.s of the structured core regions (Val3–Ile8, Cys11–Ala59, Thr61–Asp98 and Lys100–Lys115) in the ensemble from the mean structure are 0.7 Å for the backbone atoms (N—Cα—C=O) and 1.2 Å for all heavy atoms. Fig. 2(b) illustrates the single structure in the ensemble that is nearest to the mean structure and Fig. 3 shows a stereoview of this single structure. The protein consists of two domains: a four-stranded mixed β-sheet flanked by two α-helices on one face and an α-helical bundle. The α/β domain is composed of a β4–β3–β1–β2 β-sheet, with β4–β3–β1 aligned antiparallel and β1–β2 aligned parallel. α-Helix 1 (Asp12–His24) is tucked in behind β1–β2, and α7 (Pro107–Phe114) is tucked in behind β4–β3. The α/β domain is characteristic of the fold of thioredoxin-like proteins and usually contains a cis-proline on the N-terminal side of β3 that plays a role in the integrity of the active site (Martin, 1995). Bm-YffB also contains a proline, Pro93, at this position and analysis of the 13Cβ and 13Cγ chemical shifts for this residue indicates that it is also in the cis conformation (Table 2; Schubert et al., 2002). The other domain in Bm-YffB is an α-helical bundle dominated by α3 (Ala40–Thr49) and α6 (Ala76–Ala85), with three short helices [α2 (Tyr33–Glu36), α4 (Thr61–Lys65) and α5 (Glu68–Ser72)] around them. Hydrophobic interactions between the side chains of residues on the interface of these two domains, including Phe46 (α3), Thr49 (α3), Tyr6 (β1) and Leu101 (β4), assist in holding the domains together. As shown in Fig. 4, the protein contains a polarized distribution of charges on its surface, with a dominance of positive surfaces. Such a distribution of charges has been observed in the ArsC protein family, as well as for Pa-YffB, and would favor the binding of anions such as arsenate (Teplyakov et al., 2004).
3.2. profile and thermal stability of Bm-ArsC
). Fig. 5(a) shows the steady-state CD spectrum of Bm-YffB collected at 298 K. The dominant feature of the spectrum is characteristic of α-helical secondary structure: a double minimum at approximately 220 and 208 nm and an extrapolated maximum around 195 nm (Holzwarth & Doty, 1965; Greenfield, 2006). Such an observation is expected given the amount of helical structure (46%) observed in the solution structure of the protein (Figs. 2 and 3). Note that the double minimum is skewed and is more intense around 220 nm, which is likely to be due to the contributions of other elements of secondary structure to the CD steady-state spectrum.
(CD) spectroscopy is very sensitive to changes in a protein's backbone and, consequently, is a powerful tool to rapidly probe the conformation of proteins in solution and to assess the effect of variables such as pH, salt content and temperature on the structure of a protein (Woody, 1974By monitoring the increase in the ellipticity at a specific wavelength with increasing temperature, the thermal stability of a protein may be measured and a melting temperature (Tm) estimated for the transition between a structured and an unstructured state (Karantzeni et al., 2003). As shown in Fig. 5(b), a gradual increase in ellipticity at 220 nm is observed for Bm-YffB up to ∼323 K, followed by a more rapid increase in ellipticity that tails off and plateaus at ∼333 K. Visual inspection of the sample after heating to 353 K showed evidence of precipitation, indicating that the unfolding was irreversible and that the CD data may not be analyzed thermodynamically (Karantzeni et al., 2003). However, a quantitative estimation of the Tm for this transition may still be obtained by assuming a two-state model and taking a first derivative of the curve shown in Fig. 5(b) (Greenfield, 2006). The maximum of this first derivative, shown in Fig. 5(c), is 326.6 K.
3.3. Comparison with related structures
The PDB was searched for structures similar to Bm-YffB using the DALI search engine (Holm & Rosenström, 2010). The search indicated that the structure of Bm-YffB was most similar (Z score = 13.4) to that of the conserved hypothetical protein YffB from P. aeruginosa (PDB entry 1rw1 ; Teplyakov et al., 2004). This similarity is evident in Fig. 6, which shows a superposition of the two structures with the program SuperPose (Maiti et al., 2004). It is evident that both proteins have the same number of β-strands and α-helices organized into a similar two-domain structure. Indeed, using Bm-YffB residues Ser2–Lys115 the backbone r.m.s.d. is 3.78 Å between Bm-YffB and the equivalent region in Pa-YffB. Such similarity between the structures of the two proteins is reasonable given that the amino-acid sequences of the two proteins are 56% identical and 70% similar.
After Pa-YffB, the DALI search identified a number of proteins with Z scores between 11.3 and 10.0 that were annotated as arsenate reductases (ArsC) or Spx regulatory proteins. While the structure of Bm-YffB produced high DALI Z scores with these two types of proteins, the sequence identity between Bm-YffB and these proteins was only 14–27%. The Spx protein is a global transcription regulatory protein that does not bind DNA as part of its regulatory role but instead binds to the α-subunit of RNA polymerase to control gene expression in response to disulfide-stress conditions (Nakano et al., 2005). In Spx it is hypothesized that disulfide-bond formation in a CXXC motif triggers events that result in an increase in the cellular levels of thioredoxin and thioredoxin reductase (Nakano et al., 2003). Because Bm-YffB is a monomer and contains only a single cysteine residue, it is unlikely that it functions as a regulatory protein using a mechanism similar to that which may be employed by Spx. On the other hand, Bm-YffB contains a sequence that is somewhat similar to the HX3CX3R catalytic sequence motif that is important for arsenic detoxification activity in the arsenate-reductase family of proteins (ArsC; Martin et al., 2001); hence, it is more likely that Bm-YffB has a function related to arsenate reduction.
Fig. 7 shows a superposition of a representative structure of Bm-YffB (PDB entry 2kok ) with the of E. coli ArsC (Ec-ArsC) in the native form (PDB entry 1id9 ; Martin et al., 2001) using the program SuperPose (Maiti et al., 2004). Apart from an extra two-stranded β-sheet at the C-terminus of Ec-ArsC, the two structures are generally similar to each other: a four-stranded mixed β-sheet is flanked by a number of α-helices that generate a similar overall fold. One major difference between the two structures, highlighted in Fig. 7, is the presence of a triad of arginine residues, Arg60, Arg94 and Arg106 (red), in Ec-ArsC that is absent in Bm-YffB. These three arginines have been reported to be essential for enzymatic function, forming a thiasahydroxyl adduct when bound to arsenate (Martin et al., 2001). In the Bm-YffB structure only one arginine, Arg96 (black), is found in this area. Such a major structural difference suggests a difference in substrate specificity between Bm-YffB and Ec-ArsC and it has been postulated that the ArsC-YffB family of proteins might be able to bind glutathione in the absence of arsenate (Teplyakov et al., 2004).
3.4. perturbation studies with reduced glutathione
In support of the hypothesis that the ArsC-YffB family of proteins may bind glutathione in the absence of arsenate ions, it has been shown by P. aeruginosa YffB can bind glutathione (Teplyakov et al., 2004). One of the advantages of by NMR-based methods is that following the assignment of the 1H–15N HSQC spectrum, not only is it possible to quickly detect ligand binding to the protein by perturbation experiments, but, it is also possible to map the location of the binding interaction on the three-dimensional structure of the protein (Buchko et al., 1999; Zuiderweg, 2002). This is possible because protein–ligand interactions often manifest as changes in the chemical environment of the nuclei at the interface of ligand binding which are accompanied by perturbations in the measurable chemical shifts of the backbone 1HN and 15N resonances. Upon identifying the resonances that experience a binding-dependent or intensity perturbation, it is possible to map the location of the binding site onto the structure of the protein. Fig. 8 is the result of such an experiment following the titration of reduced glutathione into a 15N-labeled sample of Bm-YffB. At a 2:1 molar ratio of reduced glutathione:Bm-YffB, a subset of seven resonances are observed to shift. In Fig. 9 these perturbed resonances are mapped onto the structure of Bm-YffB and it is observed that they all cluster into one area (red) adjacent to the potential GX3CX3K catalytic sequence motif (yellow). The latter observation adds support to the hypothesis that Bm-YffB and other proteins in the YffB family may function as glutathione-dependent thiol reductases.
that4. Conclusions
The solution structure determined for Bm-YffB is similar to the reported for the YffB protein from P. aeruginosa: a four-stranded mixed β-sheet flanked by two α-helices on one side and an α-helical bundle. While the protein sequences of Bm-YffB and Pa-YffB are marginally similar to the amino-acid sequences of classical arsenate reductases (ArsC), comparison of the structures of YffB proteins and ArsC proteins suggest that the substrate specificities and mechanisms of these two families of proteins may differ. perturbation studies with reduced glutathione corroborate the hypothesis that YffB proteins may function as glutathione-dependent thiol reductases. Further biochemical and biophysical studies will be necessary in order to identify the substrate and work out the details of the mechanism before Bm-YffB may be exploited for structure-based drug design. The solution structure and biophysical data presented here for Bm-YffB will facilitate these efforts.
Acknowledgements
This research was funded by the National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services under Federal Contract No. HHSN272200700057C. The SSGCID internal ID for Bm-YffB is BrabA.00007.a. The majority of the research presented here was conducted at the W. R. Wiley Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the US Department of Energy's Office of Biological and Environmental Research (BER) program located at Pacific Northwest National Laboratory (PNNL). Battelle operates PNNL for the US Department of Energy.
References
Bhattacharjya, S., Xu, P., Gingras, R., Shaykhutdinov, R., Wu, C., Whiteway, M. & Ni, F. (2004). J. Mol. Biol. 344, 1071–1087. Web of Science CrossRef PubMed CAS Google Scholar
Bhattacharya, A., Tejero, R. & Montelione, G. T. (2007). Proteins, 66, 778–795. Web of Science CrossRef PubMed CAS Google Scholar
Bryan, C. M., Bhandari, J., Napuli, A. J., Leibly, D. J., Choi, R., Kelley, A., Van Voorhis, W. C., Edwards, T. E. & Stewart, L. J. (2011). Acta Cryst. F67, 1010–1014. Web of Science CrossRef IUCr Journals Google Scholar
Buchko, G. W., Daughdrill, G. W., de Lorimier, R., Rao, B. K., Isern, N. G., Lingbeck, J. M., Taylor, J. S., Wold, M. S., Gochin, M., Spicer, L. D., Lowry, D. F. & Kennedy, M. A. (1999). Biochemistry, 38, 15116–15128. Web of Science CrossRef PubMed CAS Google Scholar
Buchko, G. W., Tarasevich, B. J., Bekhazi, J., Snead, M. L. & Shaw, W. J. (2008). Biochemistry, 47, 13215–13222. Web of Science CrossRef PubMed CAS Google Scholar
Cavanagh, J., Palmer, A. G., Fairbrother, W. & Skelton, N. (1996). NMR Spectroscopy: Principles and Practice. San Diego: Academic Press. Google Scholar
Choi, R., Kelley, A., Leibly, D., Nakazawa Hewitt, S., Napuli, A. & Van Voorhis, W. (2011). Acta Cryst. F67, 998–1005. Web of Science CrossRef IUCr Journals Google Scholar
Corbel, M. J. (1997). Emerg. Infect. Dis. 3, 213–221. CrossRef CAS PubMed Google Scholar
Cornilescu, G., Delaglio, F. & Bax, A. (1999). J. Biomol. NMR, 13, 289–302. Web of Science CrossRef PubMed CAS Google Scholar
DeLano, W. L. (2002). PyMOL. https://www.pymol.org . Google Scholar
DelVecchio, V. G. et al. (2002). Proc. Natl Acad. Sci. USA, 99, 443–448. Web of Science CrossRef PubMed CAS Google Scholar
Farrow, N. A., Muhandiram, R., Singer, A. U., Pascal, S. M., Kay, C. M., Gish, G., Shoelson, S. E., Pawson, T., Forman-Kay, J. D. & Kay, L. E. (1994). Biochemistry, 33, 5984–6003. CrossRef CAS PubMed Web of Science Google Scholar
Goddard, T. D. & Kneller, D. G. (2008). Sparky 3. University of California, San Francisco, USA. https://www.cgl.ucsf.edu/home/sparky/ . Google Scholar
Greenfield, N. J. (2006). Nature Protoc. 6, 2527–2535. Google Scholar
Güntert, P. (2004). Methods Mol. Biol. 278, 353–378. PubMed Google Scholar
Holm, L. & Rosenström, P. (2010). Nucleic Acids Res. 38, W545–W549. Web of Science CrossRef CAS PubMed Google Scholar
Holzwarth, G. M. & Doty, P. (1965). J. Am. Chem. Soc. 87, 218–228. CrossRef PubMed CAS Web of Science Google Scholar
Karantzeni, I., Ruiz, C., Liu, C.-C. & Licata, V. J. (2003). Biochem. J. 374, 785–792. CrossRef PubMed CAS Google Scholar
Linge, J. P., Williams, M. A., Spronk, C. A., Bonvin, A. M. & Nilges, M. (2003). Proteins, 50, 496–506. Web of Science CrossRef PubMed CAS Google Scholar
Maiti, R., van Domselaar, G. H., Zhang, H. & Wishart, D. S. (2004). Nucleic Acids Res. 23, W590–W594. Web of Science CrossRef Google Scholar
Martin, J. L. (1995). Structure, 3, 245–250. CrossRef CAS PubMed Web of Science Google Scholar
Martin, P., DeMel, S., Shi, J., Gladysheva, T., Gatti, D. L., Rosen, B. P. & Edwards, B. F. (2001). Structure, 9, 1071–1081. Web of Science CrossRef PubMed CAS Google Scholar
Messens, J. & Silver, S. (2006). J. Mol. Biol. 362, 1–17. Web of Science CrossRef PubMed CAS Google Scholar
Moreno, E. & Moriyon, I. (2002). Proc. Natl Acad. Sci. USA, 99, 1–3. Web of Science CrossRef PubMed CAS Google Scholar
Mukhopadhyay, R., Rosen, B. P., Phung, L. T. & Silver, S. (2002). FEMS Microbiol. Rev. 26, 311–325. Web of Science CrossRef PubMed CAS Google Scholar
Myler, P. J., Stacy, R., Stewart, L. J., Staker, B. L., Van Voorhis, W. C. & Buchko, G. W. (2009). Infect. Disord. Drug Targets, 9, 493–506. CrossRef PubMed CAS Google Scholar
Nakano, S., Erwin, K. N., Ralle, M. & Zuber, P. (2005). Mol. Microbiol. 55, 498–510. Web of Science CrossRef PubMed CAS Google Scholar
Nakano, S., Küster-Schöck, E., Grossman, A. D. & Zuber, P. (2003). Proc. Natl Acad. Sci. USA, 100, 13603–13608. Web of Science CrossRef PubMed CAS Google Scholar
Rubinstein, E., Lang, R., Shasha, B., Hagar, B., Diamanstein, L., Joseph, G., Anderson, M. & Harrison, K. (1991). Antimicrob. Agents Chemother. 35, 1925–1927. CrossRef PubMed CAS Google Scholar
Schubert, M., Labudde, D., Oschkinat, H. & Schmieder, P. (2002). J. Biomol. NMR, 24, 149–154. Web of Science CrossRef PubMed CAS Google Scholar
Shi, H., Shi, X. & Liu, K. J. (2004). Mol. Cell. Biochem. 255, 67–78. Web of Science CrossRef PubMed CAS Google Scholar
Teplyakov, A., Pullalarevu, S., Obmolova, G., Doseeva, V., Galkin, A., Herzberg, O., Dauter, M., Dauter, Z. & Gilliland, G. L. (2004). BMC Struct. Biol. 4, 5. Google Scholar
Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E., Markley, J. L. & Sykes, B. D. (1995). J. Biomol. NMR, 6, 135–140. CrossRef CAS PubMed Google Scholar
Woody, R. W. (1974). In Peptides, Polypeptides and Proteins, edited by E. R. Blout, F. A. Bovey, M. Goodman & N. Lotan. New York: John Wiley & Sons. Google Scholar
Young, E. J. (1995). Clin. Infect. Dis. 21, 283–289. CrossRef CAS PubMed Google Scholar
Zuiderweg, E. R. (2002). Biochemistry, 41, 1–7. Web of Science CrossRef PubMed CAS Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.